Innovacell Inc.

¥444.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:504AHealthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap ¥20.05B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥434
(2.30%)
(87.42%)
Hold 6|4|6|4|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
10.33
10.32
10.34
10.35
27.10%
17.80%
7.22%
(3.66%)
Revenue¥B
0.997
1.048
1.051
1.111
9.72%
15.65%
14.90%
15.25%
Peers (US$127.3M)
Cap (US$)
PE
191.9M
—
94.71M
90.59x
Capital
TTM
5Y
10Y
Leveragex
2.952
0.207
0.221
EBIT/Intx
0.585
0.250
0.240
Own earn%
22.93
20.14
20.25
Sh yield%
38.44
52.07
50.31
Owners
Insiders/Inst%
12.21
41.02
Short interest%
4.63
SBC / revenue%
0.43
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
6–11
$1 testx
—
Incr. ROIC%
7